Interstitial Cystitis Completed Phase 3 Trials for Omalizumab (DB00043)

Also known as: Cystitis, Interstitial / Cystitis, Chronic Interstitial / Interstitial cystitis (chronic) / Chronic interstitial cystitis NOS (disorder) / Chronic interstitial cystitis NOS / Chronic interstitial cystitis (disorder) [Ambiguous] / Chronic interstitial cystitis / Chronic interstitial cystitis (disorder) / Cystitis interstitial / Cystitis ulcerative / Ulcerative cystitis (disorder)

IndicationStatusPhase
DBCOND0028936 (Interstitial Cystitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01294878Omalizumab in Interstitial Cystitis/Bladder Pain SyndromeTreatment